Mirum Pharmaceuticals Inc... (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

43.75

0.33 (0.76%)

At close: May 02, 2025, 3:59 PM

43.69

-0.14%

After-hours: May 02, 2025, 04:05 PM EDT

Mirum Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	222.5M	286.33M	28M	31.34M	142.09M	139.95M	51.96M
Short-Term Investments	57.81M	n/a	123.72M	125.2M	89.73M	104.69M	n/a
Long-Term Investments	12.53M	n/a	100M	4.98M	n/a	23.29M	n/a
Other Long-Term Assets	5.81M	4.17M	101.38M	101.79M	1.27M	324K	n/a
Receivables	78.29M	67.97M	23.99M	3.27M	n/a	n/a	n/a
Inventory	22.4M	22.31M	5.57M	1.51M	n/a	n/a	n/a
Other Current Assets	11.78M	10.94M	8.95M	5.27M	4.53M	2.7M	12K
Total Current Assets	392.79M	387.54M	190.22M	166.59M	236.35M	119.36M	51.98M
Property-Plant & Equipment	9.81M	1.99M	2.35M	2.55M	3.24M	3.73M	n/a
Goodwill & Intangibles	249.82M	252.93M	58.95M	18.74M	n/a	n/a	n/a
Total Long-Term Assets	277.97M	259.08M	162.68M	128.06M	4.51M	27.35M	n/a
Total Assets	670.75M	646.62M	352.91M	294.65M	240.86M	146.71M	51.98M
Account Payables	14.62M	7.42M	8.69M	9.17M	3.15M	3.35M	269K
Deferred Revenue	n/a	n/a	n/a	30.72M	13.41M	n/a	n/a
Short-Term Debt	n/a	n/a	931K	711K	636K	397K	n/a
Other Current Liabilities	102.57M	57.6M	37.06M	21.41M	9.24M	6.71M	15K
Total Current Liabilities	126.55M	87.06M	64.73M	42.6M	18.46M	13.08M	2.45M
Long-Term Debt	308.08M	306.42M	1.26M	1.9M	2.63M	3.25M	n/a
Other Long-Term Liabilities	10.48M	3.85M	143.63M	128.04M	45.05M	-3.21M	59.85M
Total Long-Term Liabilities	318.56M	310.89M	146.14M	131.84M	50.31M	3.29M	59.85M
Total Liabilities	445.11M	397.95M	210.87M	174.44M	68.77M	16.36M	62.3M
Total Debt	317.76M	308.14M	2.19M	2.61M	3.26M	3.65M	n/a
Common Stock	5K	5K	4K	3K	3K	2K	6.99M
Retained Earnings	-644.18M	-556.24M	-392.82M	-257.16M	-173.17M	-69.9M	-17.35M
Comprehensive Income	-373K	1.64M	-217K	-35K	83K	129K	-66.84M
Shareholders Equity	225.64M	248.67M	-392.82M	120.21M	-173.17M	-69.9M	-10.32M
Total Investments	70.34M	n/a	123.72M	130.18M	89.73M	127.98M	n/a